WW got a brief reprieve from its troubles when it added GLP-1 weight loss treatments to its services, but noted that they are a “medication, not a miracle.”

Reuters reported in April 2025 that WeightWatchers' stock, which traded as high as $100 in 2018, lost most of its value last year as the company faced revenue declines, liquidity concerns, and celebrity shareholder Oprah Winfrey's decision to exit its board.